Supplementary Figure 4 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Xiaohong Leng,Tian Ding,Hui Lin,Yan Wang,Limei Hu,Jianhua Hu,Barry W. Feig,Wei Zhang,Lajos Pusztai,W. Fraser Symmans,Yun Wang,Ralph B. Arlinghaus

DOI: https://doi.org/10.1158/0008-5472.22382558.v1

2023-01-01

Abstract:Supplementary Figure 4 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

What problem does this paper attempt to address?

Supplementary Figure 5 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Xiaohong Leng,Tian Ding,Hui Lin,Yan Wang,Limei Hu,Jianhua Hu,Barry W. Feig,Wei Zhang,Lajos Pusztai,W. Fraser Symmans,Yun Wang,Ralph B. Arlinghaus

DOI: https://doi.org/10.1158/0008-5472.22382555.v1

2023-01-01

Abstract:Supplementary Figure 5 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis
Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401678

2023-01-01

Abstract:PDF file - 570K, LCN2 promotes lung metastasis in balb/c nude mice.
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Figure 1 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Ying Chen,Hui‐Ming Hua,Songqing He,Cai Liu,Yongsheng Li,Shunze Hu,Duyun Ye,John R. Hoidal,Ping Wu,Xiaoping Chen

DOI: https://doi.org/10.1158/1535-7163.22485717

2023-01-01

Abstract:Supplementary Figure 1 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401675

2023-01-01

Abstract:PDF file - 142K, The AKT signaling pathway is partly inactivated after NGALR knockdown.
Supplementary Figure 3 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Ying Chen,Hui‐Ming Hua,Songqing He,Cai Liu,Yongsheng Li,Shunze Hu,Duyun Ye,John R. Hoidal,Ping Wu,Xiaoping Chen

DOI: https://doi.org/10.1158/1535-7163.22485711.v1

2023-01-01

Abstract:Supplementary Figure 3 from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Supplementary Figure Legends from Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II

Zhipeng Meng,Tao Li,Xiaoxiao Ma,Xiaoqiong Wang,Carl Van Ness,Yichao Gan,Hong Zhou,Jinfen Tang,Guiyu Lou,Yafan Wang,Jun Wu,Yun Yen,Rongzhen Xu,Wendong Huang

DOI: https://doi.org/10.1158/1535-7163.22497736

2023-01-01

Abstract:PDF file, 1752K, Figure S1. (Related to Figure 2) BBM suppresses the xenograft growth of Huh7 and SK-Hep-1 cells; Figure S2. (Related to Figure 3) BBM is localized in cytoplasm and affects cell survival; Figure S3. (Related to Figure 4) BBM suppressed the CD133+ population in Huh7 cells; Figure S4. (Related to Figure 5B). The chemical inhibitor of CAMKII, KN93, suppresses CD133+ population in Huh7 cells; Figure S6. (Related to Figure 6C). The knockdown of CAMKIIgamma suppresses liver cancer growth.
Supplementary Figure Legends from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Ying Chen,Hua Hao,Songqing He,Lei Cai,Yongsheng Li,Shunze Hu,Duyun Ye,John Hoidal,Ping Wu,Xiaoping Chen

DOI: https://doi.org/10.1158/1535-7163.22485699

2023-01-01

Abstract:Supplementary Figure Legends from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Lipocalin 2 Promotes Lung Metastasis of Murine Breast Cancer Cells.

Han Shi,Yuchao Gu,Jing Yang,Liang Xu,Wenyi Mi,Wengong Yu

DOI: https://doi.org/10.1186/1756-9966-27-83

IF: 12.658

2008-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:BACKGROUND:Lipocalin 2, an iron binding protein, is abnormally expressed in some malignant human cancers and may play an important role in tumor metastasis. However, the roles of lipocalin 2 in breast cancer formation and metastasis have not been clearly shown. This study aimed to investigate the roles of lipocalin 2 in breast tumor metastasis.METHODS:Lipocalin 2 was overexpressed in the metastatic 4T1 murine mammary cancer cells. The effects of lipocalin 2 overexpression on the malignancy of breast cancer cells were examined using cell proliferation assay, migration assay, invasion assay, and soft agar assay in vitro. Tumor formation and metastasis abilities were examined using a well established mouse mammary tumor model in vivo.RESULTS:Lipocalin 2 overexpression significantly enhanced the migration and invasion abilities of 4T1 cells in vitro, and lung metastasis in vivo. But overexpression of lipocalin 2 in 4T1 cells didn't affect cell proliferation and anchorage-independent growth in vitro, and primary tumor weight in vivo. Further studies demonstrated that the inhibition of the PI3K/Akt pathway could be a causative mechanism for the promotion of breast cancer migration/invasion induced by lipocalin 2 overexpression.CONCLUSION:These results clarified that lipocalin 2 could promote lung metastasis of 4T1 cells through the inhibition of the PI3K/Akt pathway, suggesting that lipocalin 2 was a potential target for therapy of breast cancer.
Supplementary Figure Legends from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Ying Chen,Hui‐Ming Hua,Songqing He,Cai Liu,Yongsheng Li,Shunze Hu,Duyun Ye,John R. Hoidal,Ping Wu,Xiaoping Chen

DOI: https://doi.org/10.1158/1535-7163.22485699.v1

2023-01-01

Abstract:Supplementary Figure Legends from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Supplementary Figure 4 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401681

2023-01-01

Abstract:PDF file - 77K, LCN2 does not affect MMP9 expression.
Supplementary Figure 1 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Xiaosong Chen,Mengmeng Zhao,Mingang Hao,Xueqing Sun,Jinglong Wang,Yan Mao,Lidong Zu,Junjun Liu,Yandong Shen,Jianhua Wang,Kunwei Shen

DOI: https://doi.org/10.1158/1541-7786.22510116

2023-01-01

Abstract:PDF file - 588K, Effects of single agent of tamoxifen, everolimus, or PI3K inhibitors (LY294002 or BKM120, BEZ-235) on MCF-7 and BT474 breast cancer cell lines after 48h and 72h treatment.
Supplementary Data from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Mengmeng Zhang,Kaiwen Zhou,Zilin Wang,Ting Liu,Laura E. Stevens,Filipa Lynce,Wendy Y. Chen,Sui Peng,Yubin Xie,Duanyang Zhai,Qianjun Chen,Yawei Shi,Huijuan Shi,Zhongyu Yuan,Xiaoping Li,Juan Xu,Zhenhai Cai,Jianping Guo,Nan Shao,Ying Lin

DOI: https://doi.org/10.1158/0008-5472.25964564.v1

2024-01-01

Abstract:Including Supplementary materials and methods and Supplementary Figure S1-6
Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401672

2023-01-01

Abstract:PDF file - 132K, LCN2 does not affect PTEN activity.
Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401687

2023-01-01

Abstract:PDF file - 131K, LCN2 does not affect ERK and NF-kB pathways.
Supplementary Figure 2 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Xiaosong Chen,Meizhong Zhao,Mingang Hao,Xueqing Sun,Jinglong Wang,Yan Mao,Lidong Zu,Junjun Liu,Yandong Shen,Jianhua Wang,Kunwei Shen

DOI: https://doi.org/10.1158/1541-7786.22510113.v1

2023-01-01

Abstract:PDF file - 471K, Growth-inhibitory effects of tamoxifen, everolimus, and various PI3K inhibitors on breast cancer cell lines.
Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401669.v1

2023-01-01

Abstract:PDF file - 344K, Endogenous HIC1 knockdown promotes cell migration and invasion in MCF-10A cells.
Supplementary Figure 2 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis

Li Qin,Ye-Lin Wu,Michael J. Toneff,Dabing Li,Lan Liao,Xiuhua Gao,Fiona T. Bane,Jean C.-Y. Tien,Yixiang Xu,Zhen Feng,Zhihui Yang,Yan Xu,Sarah M. Theissen,Yi Li,Leonie Young,Jianming Xu

DOI: https://doi.org/10.1158/0008-5472.22399166

2023-01-01

Abstract:PDF file - 198KB, Mammary tumor growth and metastasis in Tg(TVA)+RCAS-PyMT and Tg(NCOA1)x Tg(TVA)+RCAS-PyMT mice.
Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401690

2023-01-01

Abstract:PDF file - 623K, Effects of restoring HIC1 expression in MDA-468 cells.
Supplementary Figure 3 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401684

2023-01-01

Abstract:PDF file - 141K, HIC1 and LCN2 do not affect epithelial-mesenchymal transition (EMT).

Supplementary Figure 4 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Supplementary Figure 5 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 1 from Lipoxin A<sub>4</sub> and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 3 from Lipoxin A<sub>4</sub> and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure Legends from Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II

Supplementary Figure Legends from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Lipocalin 2 Promotes Lung Metastasis of Murine Breast Cancer Cells.

Supplementary Figure Legends from Lipoxin A<sub>4</sub> and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure 4 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplementary Data from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 3 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 4 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Supplementary Figure 5 from Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis

Supplementary Figure 5 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 1 from Lipoxin A&lt;sub&gt;4&lt;/sub&gt; and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure 6 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 3 from Lipoxin A&lt;sub&gt;4&lt;/sub&gt; and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure Legends from Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II

Supplementary Figure Legends from Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Lipocalin 2 Promotes Lung Metastasis of Murine Breast Cancer Cells.

Supplementary Figure Legends from Lipoxin A&lt;sub&gt;4&lt;/sub&gt; and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure 4 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplementary Data from A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer

Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplementary Figure 8 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 2 from NCOA1 Directly Targets &lt;i&gt;M-CSF1&lt;/i&gt; Expression to Promote Breast Cancer Metastasis

Supplementary Figure 1 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 3 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure 1 from Lipoxin A<sub>4</sub> and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure 3 from Lipoxin A<sub>4</sub> and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure Legends from Lipoxin A<sub>4</sub> and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: the Role of Antiangiogenesis

Supplementary Figure 2 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis